FDA this week awarded 510(k) clearance for Quidel’s Sofia Strep A fluorescent immunoassay (FIA) for the rapid detection of Group A Streptococcal infections. The company said that, when used with its ...
Marketed under the Sofia®, QuickVue®, D3® Direct Detection, Thyretain®, Triage® and InflammaDry® leading brand names, as well as under the new Solana®, AmpliVue® and Lyra® molecular diagnostic brands, ...
NEENAH, Wis., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today its partnership with Quidel Corporation (“Quidel”) in support of the Sofia®2 Fluorescent Immunoassay Analyzer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results